Updated Jul 16, 2026
Poole Jonathan has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Jonathan Poole is associated with ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on innovative medicines to address unmet medical needs in central nervous system disorders. Specific details about his role or contributions are not widely documented in public sources.
| Role | Insider |
|---|---|
| Notability | 10/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-01 | ACAD | ACADIA PHARMACEUTICALS INC | M — Option exercise | 2.0K | — |
Jonathan Poole is associated with ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on innovative medicines to address unmet medical needs in central nervous system disorders. Specific details about his role or contributions are not widely documented in public sources.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Poole Jonathan profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.